Why the study?
Does acetylcholine differ from bradykinin as a vasodilator to test endothelial venous function in healthy subjects?
Does acetylcholine differ from bradykinin as a vasodilator to test endothelial venous function in healthy subjects?
Acetylcholine and bradykinin are equally effective as venodilators for testing endothelial venous function in healthy subjects.
Answers are grounded in this paper and cite their sources.
Supports interchangeable use of either agent for venous endothelial testing in healthy subjects; leaves open validation in disease states.
INTRODUCTION: The evaluation of endothelial function has been performed in the arterial bed, but recently evaluation within the venous system has also been explored. Endothelial function studies employ different drugs that act as endothelium-dependent vasodilatory response inductors. OBJECTIVES: The aim of this study is to compare the endothelium-dependent venous vasodilator response mediated by either acetylcholine or bradykinin in healthy volunteers. METHODS AND RESULTS: Changes in vein diameter after phenylephrine-induced venoconstriction were measured to compare venodilation induced by acetylcholine or bradykinin (linear variable differential transformer dorsal hand vein technique). We studied 23 healthy volunteers; 31% were male, and the subject had a mean age of 33 +/- 8 years and a mean body mass index of 23 +/- 2 kg/m(2). The maximum endothelium-dependent venodilation was similar for both drugs (p = 0.13), as well as the mean responses for each dose of both drugs (r = 0.96). The maximum responses to acetylcholine and bradykinin also had good agreement. CONCLUSION: There were no differences between acetylcholine and bradykinin as venodilators in this endothelial venous function investigation.
No takes yet. Share an insight, caveat, or question.
Rabelo et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: